Isocitrate Dehydrogenase 3 (NAD+) alpha (IDH3A) (Middle Region) Peptide
Quick Overview for Isocitrate Dehydrogenase 3 (NAD+) alpha (IDH3A) (Middle Region) Peptide (ABIN8103510)
Target
Source
Application
-
-
Protein Region
- Middle Region
-
Purpose
- IDH3A Peptide - middle region
-
-
-
-
Application Notes
- Optimal working dilution should be determined by the investigator.
-
Comment
-
This is a synthetic peptide designed for use in combination with anti-IDH3A antibody ( ARP42238_P050). It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications. Please inquire for more details.
-
Restrictions
- For Research Use only
-
-
-
Format
- Lyophilized
-
Reconstitution
- Add 100 µL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.
-
Buffer
- Lyophilized powder
-
Storage
- -20 °C
-
Storage Comment
- For longer periods of storage, store at -20 °C. Avoid repeat freeze-thaw cycles.
-
-
- IDH3A (Isocitrate Dehydrogenase 3 (NAD+) alpha (IDH3A))
-
Background
-
Targeted Subunit: alpha, mitochondrial
Background Information: Isocitrate dehydrogenases catalyze the oxidative decarboxylation of isocitrate to 2-oxoglutarate. These enzymes belong to two distinct subclasses, one of which utilizes NAD(+) as the electron acceptor and the other NADP(+). Five isocitrate dehydrogenases
-
Molecular Weight
- 37kDa
-
Gene ID
- 3419
-
NCBI Accession
- NP_005521
-
UniProt
- P50213
Target
-